Emerson (EMR) PT Lowered to $56 at BofA/Merrill Lynch

February 4, 2015 7:45 AM

BofA/Merrill Lynch analyst Andrew Chin lowered his price target on Underperform-rated Emerson (NYSE: EMR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found